FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS

FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS

The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BAKHSHAEE,MASSOUD, WILDING,IAN ROBERT, SHER,NAAMIT, YOUNG,VICTOR, MCNAUGHTON,ALYN
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BAKHSHAEE,MASSOUD
WILDING,IAN ROBERT
SHER,NAAMIT
YOUNG,VICTOR
MCNAUGHTON,ALYN
description The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201401478B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201401478B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201401478B3</originalsourceid><addsrcrecordid>eNrjZDB38w_yDfVxDPH09wtWcPRzUXDxD3Z0d1UAiQcr-Lsp-Ed4unhGubooBHj4BwOxj2eAp0swDwNrWmJOcSovlOZmUHRzDXH20E0tyI9PLS5ITE7NSy2Jj3I0MjA0ASJzCydjYtQAAFWgKHU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS</title><source>esp@cenet</source><creator>BAKHSHAEE,MASSOUD ; WILDING,IAN ROBERT ; SHER,NAAMIT ; YOUNG,VICTOR ; MCNAUGHTON,ALYN</creator><creatorcontrib>BAKHSHAEE,MASSOUD ; WILDING,IAN ROBERT ; SHER,NAAMIT ; YOUNG,VICTOR ; MCNAUGHTON,ALYN</creatorcontrib><description>The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.</description><language>eng</language><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160928&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201401478B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160928&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201401478B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAKHSHAEE,MASSOUD</creatorcontrib><creatorcontrib>WILDING,IAN ROBERT</creatorcontrib><creatorcontrib>SHER,NAAMIT</creatorcontrib><creatorcontrib>YOUNG,VICTOR</creatorcontrib><creatorcontrib>MCNAUGHTON,ALYN</creatorcontrib><title>FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS</title><description>The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB38w_yDfVxDPH09wtWcPRzUXDxD3Z0d1UAiQcr-Lsp-Ed4unhGubooBHj4BwOxj2eAp0swDwNrWmJOcSovlOZmUHRzDXH20E0tyI9PLS5ITE7NSy2Jj3I0MjA0ASJzCydjYtQAAFWgKHU</recordid><startdate>20160928</startdate><enddate>20160928</enddate><creator>BAKHSHAEE,MASSOUD</creator><creator>WILDING,IAN ROBERT</creator><creator>SHER,NAAMIT</creator><creator>YOUNG,VICTOR</creator><creator>MCNAUGHTON,ALYN</creator><scope>EVB</scope></search><sort><creationdate>20160928</creationdate><title>FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS</title><author>BAKHSHAEE,MASSOUD ; WILDING,IAN ROBERT ; SHER,NAAMIT ; YOUNG,VICTOR ; MCNAUGHTON,ALYN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201401478B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>online_resources</toplevel><creatorcontrib>BAKHSHAEE,MASSOUD</creatorcontrib><creatorcontrib>WILDING,IAN ROBERT</creatorcontrib><creatorcontrib>SHER,NAAMIT</creatorcontrib><creatorcontrib>YOUNG,VICTOR</creatorcontrib><creatorcontrib>MCNAUGHTON,ALYN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAKHSHAEE,MASSOUD</au><au>WILDING,IAN ROBERT</au><au>SHER,NAAMIT</au><au>YOUNG,VICTOR</au><au>MCNAUGHTON,ALYN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS</title><date>2016-09-28</date><risdate>2016</risdate><abstract>The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201401478B
source esp@cenet
title FORMULATIONS AND DOSAGE FORMS OF OXIDIZED PHOSPHOLIPIDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A00%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAKHSHAEE,MASSOUD&rft.date=2016-09-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201401478B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true